S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Sell every Stock except ONE (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Sell every Stock except ONE (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Sell every Stock except ONE (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Sell every Stock except ONE (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
NASDAQ:CNXC

Concentrix - CNXC Stock Forecast, Price & News

$121.99
+4.48 (+3.81%)
(As of 10/4/2022 12:00 AM ET)
Add
Compare
Today's Range
$118.19
$122.64
50-Day Range
$109.76
$136.91
52-Week Range
$108.57
$208.48
Volume
275,479 shs
Average Volume
269,486 shs
Market Capitalization
$6.35 billion
P/E Ratio
14.15
Dividend Yield
0.85%
Price Target
$174.00

Concentrix MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
42.6% Upside
$174.00 Price Target
Short Interest
Healthy
1.63% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
0.21mentions of Concentrix in the last 14 days
Based on 20 Articles This Week
Insider Trading
Selling Shares
$67.58 M Sold Last Quarter
Proj. Earnings Growth
8.58%
From $11.31 to $12.28 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.29 out of 5 stars

Business Services Sector

9th out of 336 stocks

Business Services, Not Elsewhere Classified Industry

4th out of 103 stocks

CNXC stock logo

About Concentrix (NASDAQ:CNXC) Stock

Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It also offers customer lifecycle management; customer experience/user experience strategy and design; digital transformation; and voice of the customer and analytics solutions. The company's clients include consumer electronics, technology, e-commerce, and health insurance companies, as well as global IPOs, social brands, and banks. Concentrix Corporation was incorporated in 2009 and is based in Fremont, California.

Receive CNXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Concentrix and its competitors with MarketBeat's FREE daily newsletter.

CNXC Stock News Headlines

Company News for Sep 30, 2022 - Nasdaq
Company News for Sep 30, 2022 - Yahoo Finance
Concentrix Reports Third Quarter 2022 Results
Concentrix (CNXC) to Release Quarterly Earnings on Wednesday
See More Headlines
Receive CNXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Concentrix and its competitors with MarketBeat's FREE daily newsletter.

CNXC Company Calendar

Ex-Dividend for 8/9 Dividend
7/28/2022
Dividend Payable
8/09/2022
Last Earnings
9/29/2022
Today
10/04/2022
Ex-Dividend for 11/8 Dividend
10/27/2022
Dividend Payable
11/08/2022
Fiscal Year End
11/30/2022
Next Earnings (Estimated)
1/17/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:CNXC
Fax
N/A
Employees
290,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$174.00
High Stock Price Forecast
$174.00
Low Stock Price Forecast
$174.00
Forecasted Upside/Downside
+42.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$405.58 million
Pretax Margin
9.71%

Debt

Sales & Book Value

Annual Sales
$5.59 billion
Cash Flow
$16.35 per share
Book Value
$50.08 per share

Miscellaneous

Free Float
51,535,000
Market Cap
$6.35 billion
Optionable
Not Optionable
Beta
0.64

Key Executives

  • Mr. Christopher A. Caldwell (Age 49)
    Pres, CEO & Director
    Comp: $3.54M
  • Mr. Andre S. ValentineMr. Andre S. Valentine (Age 59)
    Chief Financial Officer
    Comp: $1.47M
  • Mr. Richard RossoMr. Richard Rosso (Age 58)
    Exec. VP of Global Sales & Account Management
    Comp: $1.19M
  • Ms. Jane FogartyMs. Jane Fogarty (Age 55)
    Exec. VP of Legal & Corp. Sec.
    Comp: $153.46k
  • Mr. Cormac J. Twomey (Age 51)
    Exec. VP of Global Operations & Delivery
    Comp: $1.18M
  • Ms. Winnie Sun
    Sr. VP of Operations & Delivery
  • Mr. David E. Stein
    VP of Investor Relations
  • Ms. Debbie Gonzalez
    Sr. VP of Global Marketing & Communications
  • Mr. Jason Marasigan
    Sr. VP of Corp. Devel.
  • Ms. Diane Hanson
    Global VP of People Solutions













CNXC Stock - Frequently Asked Questions

Should I buy or sell Concentrix stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Concentrix in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CNXC shares.
View CNXC analyst ratings
or view top-rated stocks.

What is Concentrix's stock price forecast for 2022?

1 Wall Street research analysts have issued 12 month target prices for Concentrix's shares. Their CNXC share price forecasts range from $174.00 to $174.00. On average, they predict the company's share price to reach $174.00 in the next twelve months. This suggests a possible upside of 42.6% from the stock's current price.
View analysts price targets for CNXC
or view top-rated stocks among Wall Street analysts.

How have CNXC shares performed in 2022?

Concentrix's stock was trading at $178.62 on January 1st, 2022. Since then, CNXC shares have decreased by 31.7% and is now trading at $121.99.
View the best growth stocks for 2022 here
.

When is Concentrix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, January 17th 2023.
View our CNXC earnings forecast
.

How were Concentrix's earnings last quarter?

Concentrix Co. (NASDAQ:CNXC) posted its earnings results on Thursday, September, 29th. The company reported $2.95 EPS for the quarter, missing analysts' consensus estimates of $2.97 by $0.02. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. Concentrix had a trailing twelve-month return on equity of 21.55% and a net margin of 7.39%. The company's quarterly revenue was up 13.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.35 earnings per share.

How often does Concentrix pay dividends? What is the dividend yield for Concentrix?

Concentrix declared a quarterly dividend on Wednesday, September 28th. Shareholders of record on Friday, October 28th will be paid a dividend of $0.275 per share on Tuesday, November 8th. This represents a $1.10 annualized dividend and a dividend yield of 0.90%. The ex-dividend date is Thursday, October 27th. This is an increase from the stock's previous quarterly dividend of $0.25.
Read our dividend analysis for CNXC
.

Is Concentrix a good dividend stock?

Concentrix (NASDAQ:CNXC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 0.85%. The dividend payout ratio is 11.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNXC will have a dividend payout ratio of 8.14% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNXC.

What guidance has Concentrix issued on next quarter's earnings?

Concentrix issued an update on its fourth quarter 2022 earnings guidance on Monday, October, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.67 billion-$1.67 billion, compared to the consensus revenue estimate of $1.70 billion.

When did Concentrix IPO?

(CNXC) raised $75 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 5,000,000 shares at $15.00 per share. BofA Merrill Lynch, Wells Fargo Securities, Citigroup, Jefferies, Scotia Howard Weil, Credit Suisse, J.P. Morgan, Evercore ISI, BB&T Capital Markets, Goldman, Sachs, The Huntington Investment Company, Stifel and Nomura served as the underwriters for the IPO and Clarksons Platou Securities, Cowen and Company and Tuohy Brothers were co-managers.

What is Concentrix's stock symbol?

Concentrix trades on the NASDAQ under the ticker symbol "CNXC."

How do I buy shares of Concentrix?

Shares of CNXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Concentrix's stock price today?

One share of CNXC stock can currently be purchased for approximately $121.99.

How much money does Concentrix make?

Concentrix (NASDAQ:CNXC) has a market capitalization of $6.35 billion and generates $5.59 billion in revenue each year. The company earns $405.58 million in net income (profit) each year or $8.62 on an earnings per share basis.

How many employees does Concentrix have?

The company employs 290,000 workers across the globe.

How can I contact Concentrix?

The official website for the company is www.concentrix.com. The company can be reached via phone at 800-747-0583 or via email at david.stein@concentrix.com.

This page (NASDAQ:CNXC) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.